ilmofosine has been researched along with thymidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berdel, WE; Eibl, H; Fink, U; Fromm, M; Jehn, U; Rastetter, J; Reichert, A; Schick, HD; Ulm, K; Unger, C | 1 |
| Berdel, WE; Bicker, U; Fink, U; Fromm, M; Pahlke, W; Rastetter, J; Reichert, A; Schick, HD | 1 |
2 other study(ies) available for ilmofosine and thymidine
| Article | Year |
|---|---|
Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cell Survival; Cytotoxins; Humans; Leukemia; Organophosphates; Phospholipid Ethers; Platelet Activating Factor; Thymidine; Tumor Cells, Cultured | 1987 |
Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cell Survival; Humans; Leukemia; Lysophospholipids; Organophosphates; Organophosphorus Compounds; Phospholipid Ethers; Thymidine; Tumor Cells, Cultured | 1987 |